Sinovac Research and Development Co., Ltd.
22
0
0
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
9.1%
2 terminated/withdrawn out of 22 trials
88.2%
+1.7% vs industry average
68%
15 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Role: lead
Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above
Role: lead
Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years
Role: lead
Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents
Role: lead
Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years
Role: lead
Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
Role: lead
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
Role: lead
Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults
Role: lead
Immunogenicity of an Inactivated COVID-19 Vaccine
Role: lead
Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong
Role: lead
Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above
Role: lead
Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose
Role: lead
Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic
Role: lead
Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey
Role: lead
Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19
Role: lead
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
Role: lead
Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
Role: lead
Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)
Role: lead
Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Role: lead
Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
Role: lead